Acropolis Investment Management LLC Has $3.21 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Acropolis Investment Management LLC reduced its holdings in UnitedHealth Group by 8.9%, selling 1,004 shares during the second quarter and bringing their total to 10,294 shares valued at approximately $3.21 million.
• UnitedHealth Group's quarterly earnings report revealed earnings per share (EPS) of $4.08, which was below the consensus estimate of $4.45, despite a revenue of $111.62 billion.
• The company announced a $2.21 quarterly dividend for stockholders, reflecting an annualized dividend of $8.84 and a yield of 2.6%, with a payout ratio of 38.30%.

Acropolis Investment Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,294 shares of the healthcare conglomerate's stock after selling 1,004 shares during the period. Acropolis Investment Management LLC's holdings in UnitedHealth Group were worth $3,211,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Vanguard Group Inc. raised its stake in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP increased its stake in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. GAMMA Investing LLC lifted its position in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the period. Bank of New York Mellon Corp grew its stake in shares of UnitedHealth Group by 2.5% in the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after buying an additional 196,696 shares in the last quarter. Finally, Nuveen LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $3,846,764,000. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research note on Friday, September 12th. Bank of America raised their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Finally, Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Trading Up 1.4%

Shares of UNH stock traded up $4.80 on Monday, hitting $341.49. 8,883,715 shares of the stock traded hands, compared to its average volume of 13,684,542. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The stock has a market capitalization of $309.27 billion, a PE ratio of 14.80, a PEG ratio of 2.20 and a beta of 0.44. The firm's 50-day moving average price is $296.49 and its two-hundred day moving average price is $362.50.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.